Assembly Biosciences Financial Overview
Assembly Biosciences's market cap is currently $557.71M. The company's EPS TTM is $-0.72; its P/E ratio is -7.34; Assembly Biosciences is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.85. See an overview of income statement, balance sheet, and cash flow financials.
